FLAM

First Light Asset Management Portfolio holdings

AUM $771M
This Quarter Return
+1.61%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.4B
AUM Growth
+$1.4B
Cap. Flow
-$32.5M
Cap. Flow %
-2.32%
Top 10 Hldgs %
47.37%
Holding
90
New
7
Increased
27
Reduced
20
Closed
11

Top Buys

1
ATRC icon
AtriCure
ATRC
$24.9M
2
KROS icon
Keros Therapeutics
KROS
$22.2M
3
BLU
BELLUS Health Inc.
BLU
$18.7M
4
BCYC
Bicycle Therapeutics
BCYC
$16.3M
5
FNA
Paragon 28, Inc.
FNA
$12.8M

Top Sells

1
ALDX icon
Aldeyra Therapeutics
ALDX
$26.2M
2
XBI icon
SPDR S&P Biotech ETF
XBI
$25.7M
3
YMAB icon
Y-mAbs Therapeutics
YMAB
$16.5M
4
INSM icon
Insmed
INSM
$14.4M
5
OPRX icon
OptimizeRx
OPRX
$12M

Sector Composition

1 Healthcare 84.7%
2 Communication Services 5.48%
3 Energy 0.15%
4 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TAK icon
76
Takeda Pharmaceutical
TAK
$47.8B
$349K 0.03%
25,630
– –
MCK icon
77
McKesson
MCK
$85.9B
$335K 0.02%
1,346
– –
SNY icon
78
Sanofi
SNY
$122B
$333K 0.02%
6,650
– –
UHS icon
79
Universal Health Services
UHS
$11.6B
$266K 0.02%
2,050
– –
HRC
80
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-4,346
Closed -$652K
TCRR
81
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-620,887
Closed -$5.28M
APTO
82
DELISTED
Aptose Biosciences, Inc.
APTO
– –
-4,128,443
Closed -$9M
NVTA
83
DELISTED
Invitae Corporation
NVTA
– –
-256,367
Closed -$7.29M
YMAB icon
84
Y-mAbs Therapeutics
YMAB
$390M
– –
-577,663
Closed -$16.5M
XBI icon
85
SPDR S&P Biotech ETF
XBI
$5.29B
– –
-204,600
Closed -$25.7M
WW
86
DELISTED
WW International
WW
– –
-458,273
Closed -$8.36M
STIM icon
87
Neuronetics
STIM
$216M
– –
-1,458,818
Closed -$9.57M
RLAY icon
88
Relay Therapeutics
RLAY
$709M
– –
-51,848
Closed -$1.64M
EBS icon
89
Emergent Biosolutions
EBS
$418M
– –
-4,294
Closed -$215K
ALDX icon
90
Aldeyra Therapeutics
ALDX
$350M
– –
-2,985,712
Closed -$26.2M
1 2 3
4